Margaret M. Stratton

Dr. Margaret M. Stratton


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Cell Reports
Verified
Journal Article
Open access
CÖCan Özden
Can Özden
RSRoman Sloutsky
Roman Sloutsky
TMTomohiro Mitsugi
Tomohiro Mitsugi
NSNicholas Santos
Nicholas Santos
EAEmily Agnello
Emily Agnello
MSMargaret M. Stratton
Margaret M. Stratton
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a signaling protein required for long-term memory. When activated by Ca2+/CaM, it sustains activity even after the Ca2+ dissipates. In addition to the well-known autophosphorylation-mediated mechanism, interaction with specific binding partners also persistently activates CaMKII. A long-standing model invokes two distinct S and T sites. If an interactor binds at the T-site, then it will preclude autoinhibition and allow substrates to be phosphorylated at the S site. Here, we specifically test this model with X-ray crystallography, molecular dynamics simulations, and biochemistry. Our data are inconsistent with this model. Co-crystal structures of four different activators or substrates show that they all bind to a single continuous site across the kinase domain. We propose a mechanistic model where persistent CaMKII activity is facilitated by high-affinity binding partners that kinetically compete with autoinhibition by the regulatory segment to allow substrate phosphorylation.

21 July 2020 in Science Signaling
Verified
Journal Article
Closed access
RSRoman Sloutsky
Roman Sloutsky
NDNoelle Dziedzic
Noelle Dziedzic
MDMatthew J. Dunn
Matthew J. Dunn
RBRachel M. Bates
Rachel M. Bates
ATAna P. Torres-Ocampo
Ana P. Torres-Ocampo
MSMargaret M. Stratton
Margaret M. Stratton
Structural and functional analyses suggest that the hub domain of CaMKII regulates kinase activity.

26 May 2020 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
RSRoman Sloutsky
Roman Sloutsky
MSMargaret M. Stratton
Margaret M. Stratton

13 April 2020 in Protein Science
Verified
Journal Article
Closed access
PDF file
ATAna P. Torres‐Ocampo
Ana P. Torres‐Ocampo
CÖCan Özden
Can Özden
AHAlexandra Hommer
Alexandra Hommer
AGAnne Gardella
Anne Gardella
ELEmily Lapinskas
Emily Lapinskas
MSMargaret M. Stratton
Margaret M. Stratton

1 August 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GAGoli Ardestani
Goli Ardestani
MWMegan C. West
Megan C. West
TMThomas J. Maresca
Thomas J. Maresca
RFRafael A. Fissore
Rafael A. Fissore
MSMargaret M. Stratton
Margaret M. Stratton
Ca2+ oscillations and consequent Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation are required for embryogenesis, as well as neuronal, immunological, and cardiac signaling. Fertilization directly results in Ca2+ oscillations, but the resultant pattern of CaMKII activity remains largely unclear. To address this gap, we first employed the one existing biosensor for CaMKII activation. This sensor, Camui, comprises CaMKIIα and therefore solely reports on the activation of this CaMKII variant. Additionally, to detect the activity of all endogenous CaMKII variants simultaneously, we constructed a substrate-based sensor for CaMKII activity, FRESCA (FRET-based sensor for CaMKII activity). To examine the differential responses of the Camui and FRESCA sensors, we used several approaches to stimulate Ca2+ release in mouse eggs, including addition of phospholipase Cζ cRNA, which mimics natural fertilization. We found that the Camui response is delayed or terminates earlier than the FRESCA response. FRESCA enables assessment of endogenous CaMKII activity in real-time by both fertilization and artificial reagents, such as Sr2+, which also leads to CaMKII activation. FRESCA's broad utility will be important for optimizing artificial CaMKII activation for clinical use to manage infertility. Moreover, FRESCA provides a new view on CaMKII activity, and its application in additional biological systems may reveal new signaling paradigms in eggs, as well as in neurons, cardiomyocytes, immune cells, and other CaMKII-expressing cells.

13 March 2023 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
SSSarthak Saha
Sarthak Saha
CÖCan Özden
Can Özden
ASAlfred Samkutty
Alfred Samkutty
SRSilvia Russi
Silvia Russi
ACAina Cohen
Aina Cohen
Sarah PerrySarah Perry
Sarah Perry
Proteins are long chains of amino acid residues that perform a myriad of functions in living organisms, including enzymatic reactions, signalling, and maintaining structural integrity. Protein function is determined directly by the protein structure. X-ray crystallography is the primary technique for determining the 3D structure of proteins, and facilitates understanding the effects of protein structure on function. The first step towards structure determination is crystallizing the protein of interest. We have developed a centrifugally-actuated microfluidic device that incorporates the fluid handling and metering necessary for protein crystallization. Liquid handling takes advantage of surface forces to control fluid flow and enable metering, without the need for any fluidic or pump connections. Our approach requires only the simple steps of pipetting the crystallization reagents into the device followed by either spinning or shaking to set up counter-diffusive protein crystallization trials. The use of thin, UV-curable polymers with a high level of X-ray transparency allows for in situ X-ray crystallography, eliminating the manual handling of fragile protein crystals and streamlining the process of protein structure analysis. We demonstrate the utility of our device using hen egg white lysozyme as a model system, followed by the crystallization and in situ, room temperature structural analysis of the hub domain of calcium–calmodulin dependent kinase II (CaMKIIβ).